Albireo Pharma (ALBO) PT Raised to $68 at H.C. Wainwright Oct 12, 2022 12:08PM
H.C. Wainwright Reiterates Buy Rating, $80 Price Target on Albireo Pharma (ALBO) Jul 7, 2022 06:12AM
H.C. Wainwright Reiterates Buy Rating on Albireo Pharma (ALBO), "We Remain Highly Confident in Bylvay's Likelihood of Success" Mar 29, 2022 11:06AM
H.C. Wainwright Reiterates Buy Rating on Albireo Pharma (ALBO), Estimates Peak Bylvay PFIC Sales of $446M Feb 23, 2022 07:42AM
Albireo Pharma (ALBO) Bylvay Launch Faster Than Anticipated, Raising Estimates - H.C. Wainwright Jan 7, 2022 06:46AM


Nov 5, 2021 12:12PM Albireo Pharma (ALBO) PT Raised to $80 at H.C. Wainwright
May 24, 2021 11:13AM Albireo Pharma (ALBO) PT Raised to $76 at H.C. Wainwright, Following Clinical Business Update
Sep 8, 2020 12:22PM Albireo Pharma (ALBO) PT Raised to $67 at H.C. Wainwright
Jul 16, 2020 10:45AM Albireo Pharma (ALBO) PT Raised to $64 at H.C. Wainwright
Feb 28, 2019 07:04AM H.C. Wainwright Starts Albireo Pharma (ALBO) at Buy